A significant study revealed that women who start hormone replacement therapy around menopause experience less cognitive decline and a lower risk of fractures. Despite these benefits, a controversial announcement from a doctor led to widespread fear and misinformation about the therapy's link to breast cancer, resulting in millions of women missing out on its advantages. The initial data was misrepresented, perpetuating a medical dogma that has denied many the opportunity for improved health post-menopause.
